These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 5002903

  • 1. Prototype of a fully automated device for determination of bacterial antibiotic susceptibility in the clinical laboratory.
    Isenberg HD, Reichler A, Wiseman D.
    Appl Microbiol; 1971 Dec; 22(6):980-6. PubMed ID: 5002903
    [Abstract] [Full Text] [Related]

  • 2. [Susceptibility testing with the autobac system (author's transl)].
    Baars B, Opferkuch W.
    Immun Infekt; 1978 Dec; 6(6):270-3. PubMed ID: 103806
    [Abstract] [Full Text] [Related]

  • 3. Laboratory experiments with uropathogenic bacteria and chlorhexidine.
    Korner B, Kühle P, Christensen SC.
    Acta Chir Scand Suppl; 1973 Dec; 433():110-2. PubMed ID: 4196567
    [No Abstract] [Full Text] [Related]

  • 4. The amount of agar in antimicrobic disk susceptibility test plates.
    Barry AL, Fay GD.
    Am J Clin Pathol; 1973 Feb; 59(2):196-8. PubMed ID: 4631582
    [No Abstract] [Full Text] [Related]

  • 5. Determining antibiotic levels in the blood.
    Edberg SC, Chu A.
    Am J Med Technol; 1975 Mar; 41(3):99-105. PubMed ID: 1090163
    [Abstract] [Full Text] [Related]

  • 6. [Gentamicin susceptibility of gram-negative problem germs and staphylococci, indicated by the tube dilution method].
    Modde H.
    Pathol Microbiol (Basel); 1972 Mar; 38(4):286-95. PubMed ID: 4565703
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
    De Rosa F, Tassi C, Stagni GR.
    Ann Sclavo; 1974 Mar; 16(1):65-72. PubMed ID: 4214247
    [No Abstract] [Full Text] [Related]

  • 8. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R, Koch UJ.
    Chemotherapy; 1973 Mar; 18(4):242-52. PubMed ID: 4571975
    [No Abstract] [Full Text] [Related]

  • 9. Bacterial profile and antibacterial susceptibility of otitis media among pediatric patients in Hawassa, Southern Ethiopia: cross-sectional study.
    Tadesse B, Shimelis T, Worku M.
    BMC Pediatr; 2019 Nov 01; 19(1):398. PubMed ID: 31672140
    [Abstract] [Full Text] [Related]

  • 10. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
    Eke PI, Rotimi VO.
    Afr J Med Med Sci; 1987 Mar 01; 16(1):1-8. PubMed ID: 3037870
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial action of complexing compounds. The influence of disodium versenate on microorganisms in vitro.
    Kośmider S, Rogala D, Kapp-Burzyńska Z.
    Arch Immunol Ther Exp (Warsz); 1972 Mar 01; 20(6):931-7. PubMed ID: 4197730
    [No Abstract] [Full Text] [Related]

  • 12. Rapid antimicrobial susceptibility testing of urinary tract isolates and samples by flow cytometry.
    Gauthier C, St-Pierre Y, Villemur R.
    J Med Microbiol; 2002 Mar 01; 51(3):192-200. PubMed ID: 11871613
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis].
    Lee KK, Kim ST, Hong KS, Huh HJ, Chae SL.
    Korean J Lab Med; 2008 Jun 01; 28(3):185-90. PubMed ID: 18594169
    [Abstract] [Full Text] [Related]

  • 14. A Multiplex Fluidic Chip for Rapid Phenotypic Antibiotic Susceptibility Testing.
    Wistrand-Yuen P, Malmberg C, Fatsis-Kavalopoulos N, Lübke M, Tängdén T, Kreuger J.
    mBio; 2020 Feb 25; 11(1):. PubMed ID: 32098819
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009-2016).
    Zanichelli V, Huttner A, Harbarth S, Kronenberg A, Huttner B, Swiss Centre For Antibiotic Resistance Anresis.
    Swiss Med Wkly; 2019 Jul 15; 149():w20110. PubMed ID: 31340052
    [Abstract] [Full Text] [Related]

  • 16. In vitro studies with sisomicin and gentamicin.
    Shadomy S, Utz CJ, Shadomy HJ.
    Chemotherapy; 1976 Jul 15; 22(6):346-52. PubMed ID: 821725
    [Abstract] [Full Text] [Related]

  • 17. [Synthetic medium for testing of susceptibility. II. Susceptibility of bacteria to sulphonamides (author's transl)].
    Abdou MA.
    Zentralbl Bakteriol Orig A; 1975 Jan 15; 230(1):86-103. PubMed ID: 241178
    [Abstract] [Full Text] [Related]

  • 18. [Antibiotic resistance: from the results of ONERBA's networks to good antibiotic use].
    Delarbre JM, Dubouix A, Robert J, Conseil Scientifique de l'ONERBA.
    Med Mal Infect; 2005 Jun 15; 35 Suppl 2():S108-11. PubMed ID: 16144065
    [No Abstract] [Full Text] [Related]

  • 19. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR, de Freitas AL, Willers DM, Barth AL, Zavascki AP.
    J Antimicrob Chemother; 2010 Nov 15; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q, Zhang H, Cheng J, Xu Z, Xu Y, Cao B, Kong H, Ni Y, Yu Y, Sun Z, Hu B, Huang W, Wang Y, Wu A, Feng X, Liao K, Shen D, Hu Z, Chu Y, Lu J, Su J, Gui B, Duan Q, Zhang S, Shao H.
    Int J Antimicrob Agents; 2015 May 15; 45(5):485-90. PubMed ID: 25600890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.